Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
New Developments in Depression and Anxiety Disorders
1
x
$
30.00
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
1
x
$
30.00
Jennifer L. Donovan, PhD: A Primer on Caffeine Pharmacology and Its Drug Interactions in Clinical Psychopharmacology
1
x
$
30.00
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
1
x
$
30.00
Akinetic Mutism Following Bilateral Infarcts Associated with a Mitral Valve Papillary Fibroelastoma
1
x
$
30.00
VOL 3 No. 11 Full Issue - November 2001
1
x
$
20.00
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
1
x
$
30.00
Challenges in Transitioning from Methadone to Buprenorphine- Naloxone for Chronic Pain Management: Two Cases
1
x
$
30.00
View Cart
Checkout
Home
statistical-significance
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?
$
30.00
Add to cart
Details
Page load link
Go to Top
